Pfizer and Unilab take legal aim in Philippine atorvastatin spat
This article was originally published in Scrip
Pfizer has filed suit against one of the Philippines' largest drug companies, United Laboratories (Unilab), claiming the infringement of a local patent for Lipitor (atorvastatin).
You may also be interested in...
Positive clinical results pave path forward for Japanese firm’s potential istradefylline successor.
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.